Impact of Insomnia Treatment on Brain Responses During Resting-state &

Status Recruiting

Clinical Trial Summary

Individuals with chronic insomnia have persistent difficulty falling and staying asleep, as well as complaints of altered daytime functioning that may be associated with cognitive impairments. The neural processes underlying these daytime complaints may involve abnormal activation of brain regions and neural networks involved in working memory, memory encoding and emotions. The goal of this study is to assess whether a psychological treatment for insomnia will reverse these abnormalities in brain responses to cognitive tasks and at rest. A secondary objective of the study is to characterize impairments in attentional processing and assess if the impairments can be reversed by the psychological treatment. We hypothesized that the psychological treatment for insomnia will lead to a normalization of the brain responses to working memory, declarative memory encoding, insomnia-related stimuli, and the functional connectivity within the default-mode and limbic networks.

Clinical Trial Description

Study hypothesis Brain responses associated with working memory task and declarative memory encoding will be decreased in chronic insomnia compared to good sleepers and, among individuals with chronic insomnia, cognitive-behavioral therapy for insomnia will lead to larger recovery in these brain responses, compared to a 3-month wait period. Brain responses to emotional stimulation, especially to insomnia-related stimuli, will be increased in chronic insomnia compared to good sleepers, and, among individuals with chronic insomnia, cognitive-behavioral therapy for insomnia will lead to larger reduction in these brain responses, compared to a 3-month wait period. Connectivity in the default-mode and limbic networks during resting-state will be increased in chronic insomnia compared to good sleepers, and, among individuals with chronic insomnia, cognitive-behavioral therapy for insomnia will lead to larger reduction in this connectivity, compared to a 3-month wait period. ;

Study Design

Related Conditions & MeSH terms

Chronic Insomnia
Sleep Initiation and Maintenance Disorders

Clinical Trial Details

NCT number	NCT04024787
Study type	Interventional
Source	Concordia University, Montreal
Contact	Thanh Dang-Vu, MD PhD
Phone	514-848-2424
Email	tt.dangvu@concordia.ca
Status	Recruiting
Phase	N/A
Start date	July 30, 2019
Completion date	July 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03171519` - Effects of Exercise and Acupuncture on Chronic Insomnia	N/A
Completed	`NCT02515006` - Impact of Homeopathy for Persistent Insomnia in Patients With Cancer	N/A
Recruiting	`NCT05247697` - Mirtazapine for Chronic Insomnia in Older Adults	Phase 1
Active, not recruiting	`NCT04366284` - Optimizing the Scalability of Evidence-Based Behavioral Sleep Medicine Practices With a Digital Health Platform	N/A
Active, not recruiting	`NCT04350866` - Enhancing Access to Insomnia Care in VA PCMHI Clinics
Recruiting	`NCT04761796` - Sleep Time and Insomnia Factors Among Professional Flight Members
Completed	`NCT02688569` - Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study	N/A
Completed	`NCT02236845` - Pilot Study to Clinical Evaluate Lacrima Medical Device in Insomnia Patients	N/A
Completed	`NCT01949389` - Piloting an Internet-based Therapy for Insomnia in a Population of Veterans With Substance Use Disorders	N/A
Completed	`NCT00414102` - Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.	Phase 4
Completed	`NCT00671294` - Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.	Phase 3
Completed	`NCT02392000` - Mobile Sleep Intervention for OEF, OIF and OND Veterans	N/A
Recruiting	`NCT04471168` - Interest of Auriculotherapy in the Management of Chronic Insomnia	N/A
Completed	`NCT02774642` - Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study)	N/A
Completed	`NCT02290405` - Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers
Completed	`NCT05618002` - Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients
Completed	`NCT01995838` - A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia	Phase 2
Recruiting	`NCT05457790` - Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)	N/A
Active, not recruiting	`NCT02272712` - The Effectiveness of Online Treatment for Insomnia in Cancer Survivors	N/A
Completed	`NCT00915135` - Efficacy and Safety of Ramelteon on Chronic Insomnia	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Impact of Insomnia Treatment on Brain Responses During Resting-state and Cognitive Tasks

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms